Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/60803
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHiwase, Devendraen
dc.contributor.authorWhite, Deborah Leeen
dc.contributor.authorSaunders, Verity Annen
dc.contributor.authorKumar, Shajien
dc.contributor.authorMelo, Junia V.en
dc.contributor.authorHughes, Timothy Peteren
dc.date.issued2009en
dc.identifier.citationLeukemia, 2009; 23(6):1205-1206en
dc.identifier.issn0887-6924en
dc.identifier.urihttp://hdl.handle.net/2440/60803-
dc.description.statementofresponsibilityD.K. Hiwase, D.L. White, V.A. Saunders, S. Kumar, J.V. Melo and T.P. Hughesen
dc.language.isoenen
dc.publisherNature Publishing Groupen
dc.rightsCopyright status unknownen
dc.titleShort-term intense Bcr–Abl kinase inhibition with nilotinib is adequate to trigger cell death in BCR-ABL⁺ cellsen
dc.title.alternativeShort-term intense Bcr-Abl kinase inhibition with nilotinib is adequate to trigger cell death in BCR-ABL(+) cellsen
dc.typeJournal articleen
dc.contributor.schoolHealth Sciences Faculty Officeen
dc.identifier.doi10.1038/leu.2009.45en
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.